First-in-human validation of a DROP-IN β-probe for robotic radioguided surgery: defining optimal signal-to-background discrimination algorithm

Francesco Collamati,Silvio Morganti,Matthias N. van Oosterom,Lorenzo Campana,Francesco Ceci,Stefano Luzzago,Carlo Mancini-Terracciano,Riccardo Mirabelli,Gennaro Musi,Francesca Nicolanti,Ilaria Orsi,Fijs W. B. van Leeuwen,Riccardo Faccini
DOI: https://doi.org/10.1007/s00259-024-06653-6
2024-02-21
Abstract:In radioguided surgery (RGS), radiopharmaceuticals are used to generate preoperative roadmaps (e.g., PET/CT) and to facilitate intraoperative tracing of tracer avid lesions. Within RGS, there is a push toward the use of receptor-targeted radiopharmaceuticals, a trend that also has to align with the surgical move toward minimal invasive robotic surgery. Building on our initial ex vivo evaluation, this study investigates the clinical translation of a DROP-IN β probe in robotic PSMA-guided prostate cancer surgery.
What problem does this paper attempt to address?